Drospirenone Impurity 12 | CAS 18171-15-8 - Request Quote
Drospirenone Impurity 12
| SZ CAT No: | SZ-D013040 |
| CAS No | 18171-15-8 |
| Mol.F. | C6H15ClOSi |
| Mol.Wt. |
166.7 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Drospirenone Impurity 12 is chemically (3-Chloropropoxy)trimethylsilane. Drospirenone Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Drospirenone Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Drospirenone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 18171-15-8
Purchase 18171-15-8
Order 18171-15-8
Enquire 18171-15-8
price of 18171-15-8
18171-15-8 Supplier
18171-15-8 Manufacturer
18171-15-8 Exporter
buy high quality Drospirenone Impurity 12
Purchase Drospirenone Impurity 12
Drospirenone Impurity 12 suppliers
Drospirenone Impurity 12 manufacturers
Drospirenone Impurity 12 price
Order Drospirenone Impurity 12
Enquire Drospirenone Impurity 12
Drospirenone Impurity 12 cost
Drospirenone Impurity 12 Supplier
Drospirenone Impurity 12 Distributor
Drospirenone Impurity 12 for Method Validation
Drospirenone Reference Standard
Drospirenone Impurity 12 for ANDA Filing
Drospirenone Impurity 12 for Forced Degradation Studies
Drospirenone Impurity 12 Identification Standards
Drospirenone Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.